透云生物旗下「莱茵衣藻」获批为国家新食品原料 May 16, 2022 09:38 HKT |  |
|
透雲生物旗下「萊茵衣藻」獲批為國家新食品原料 May 16, 2022 09:37 HKT |  |
|
祝贺!国际顶级医学期刊《自然-医学》同时发表两篇关于华领医药全球首创糖尿病新药多格列艾汀的III期研究结果的同行评议论文 May 13, 2022 11:18 HKT | |
|
祝賀!國際頂級醫學期刊《自然-醫學》同時發表兩篇關於華領醫藥全球首創糖尿病新藥多格列艾汀的III期研究結果的同行評議論文 May 13, 2022 11:17 HKT | |
|
Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine May 13, 2022 11:16 HKT | |
|
노보텍, 프리-ASCO중국 서밋 후원: 초기 단계 종양학 임상에 기반해 진행 여부 결정 May 12, 2022 21:00 HKT |  |
|
Q&M Dental net profit, excluding other gains or losses, increased by 25% to S$7.2 million on S$46.8 million of revenue for quarter ended 31 March 2022 May 12, 2022 09:00 HKT |  |
|
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials May 12, 2022 06:00 HKT |  |
|
Novotech 赞助 ASCO 中国峰会前夕:基于早期肿瘤学试验的 Go/No Go 决策 May 12, 2022 06:00 HKT |  |
|
Novotech 贊助 ASCO 中國峰會前夕:基於早期腫瘤學試驗的 Go/No Go 決策 May 12, 2022 06:00 HKT |  |
|
Sirnaomics在TIDES USA 2022上汇报其基于GalNAc-肝脏靶向技术平台和GalAhead™技术及相关项目的最新进展 May 11, 2022 14:35 HKT | |
|
Sirnaomics在TIDES USA 2022上匯報其基於GalNAc-肝臟靶向技術平台和GalAhead™技術及相關項目的最新進展 May 11, 2022 14:34 HKT | |
|
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead(TM) Programs at the TIDES USA 2022 May 11, 2022 14:33 HKT | |
|
노보텍, 미국 임상시험수탁기관 인수 - 글로벌 전문성 확대 May 05, 2022 09:00 HKT |  |
|
Novotech Acquires US CRO NCGS, Expands Global Expertise May 05, 2022 09:00 HKT |  |
|
Novotech收购美国合同研究组织(CRO),拓展全球专业领域 May 05, 2022 09:00 HKT |  |
|
Novotech收購美國合同研究組織(CRO),拓展全球專業領域 May 05, 2022 09:00 HKT |  |
|
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry May 05, 2022 04:05 HKT |  |
|
Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara's Ramadhan Initiative Apr 28, 2022 11:30 HKT |  |
|
Legend Capital's Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis Apr 27, 2022 16:09 HKT |  |
|